Skip to main content
Right Decisions for Health and Care
A navigation link to the homepage.
Right Decisions for Health and Care
  • All resources
  • Organisations
  • Learning & support
  • How to deliver RDS tools
  • Feedback
  1. Right Decisions
  2. DGRefHelp - NHS Dumfries & Galloway
  3. Back
  4. Rheumatology
  5. DMARD monitoring protocols
Announcements and latest updates

test announcement

DMARD monitoring protocols

DGRefHelp - NHS Dumfries & Galloway
NHS Dumfries and Galloway

Azathioprine

Ciclosporin

Hydroxychloroquine

Immunosuppressant biologic treatment in rheumatology

Leflunomide

Mepacrine

Methotrexate

Minocycline

Mycophenolate mofetil (MMF)

Parenteral gold (Myocrisin)

Subcutaneous methotrexate

Sulfasalazine

Right Decisions for Health and Care

  • About the Right Decision Service
  • Terms and conditions of your use of the Right Decisions Platform (RDP)
  • Content provider terms and conditions of use of the Right Decisions Platform (RDP)
  • Accessibility & browser/device compatibility
  • Using screen readers

Downloads

  • Download the app on the Apple store
  • Download the app on the Google Play store

Powered by QURIS v7.14.2 © 2025.
Back to the top